-
公开(公告)号:US20210113537A1
公开(公告)日:2021-04-22
申请号:US16493931
申请日:2018-03-16
Applicant: Eisai R&D Management Co., Ltd.
Inventor: Craig D. KARR , Manav KORPAL , Nathalie RIOUX , Peter Gerard SMITH
IPC: A61K31/445 , A61K31/519 , A61K45/06 , A61P35/00
Abstract: Provided herein is a combination therapy useful for the treatment breast cancer. The combination comprises an ER-alpha inhibitor and a CDK 4/6 inhibitor.